arrow
F

Finn Sellebjerg

University of Copenhagen
H指数:69
被引数:2.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Are exercise booster sessions effective at preserving exercise-induced effects in people with multiple sclerosis? A randomised controlled trial: results from the MSBOOST trial

运动增强干预对维持多发性硬化患者运动诱导效应的效果如何?一项随机对照试验:MSBOOST试验的结果

2026-07-011
PRE
Blood-brain barrier integrity and prevalence of intrathecal T helper 17.1 cells in Huntingtons disease

血脑屏障完整性与亨廷顿病中鞘内辅助性T细胞17.1的患病率

2026-01-120
PRE
Non-inferiority of Rituximab versus OCrelizumab in Multiple Sclerosis (ROC-MS) – an Individual Participant Data Meta-Analysis

利妥昔单抗相较于奥瑞珠单抗在多发性硬化中的非劣效性(ROC-MS)——一项个体参与者数据meta分析

2025-11-110
OAAI
Profiling the Cerebrospinal Fluid Proteome in Progressive Multiple Sclerosis: Treatment Effects and Associations with IgM Oligoclonal Bands

对进行性多发性硬化症脑脊液蛋白质组的分析:治疗效果与IgM寡克隆带的相关性

2025-10-300
OA
Prevalence of Tick-borne Neoehrlichia mikurensis in Individuals Undergoing B-cell Depleting Therapy in Denmark: A Prospective Cohort Study 2023-2024

2023-2024年丹麦B细胞耗竭治疗个体中蜱传Neoehrlichia mikurensis的流行率:一项前瞻性队列研究

2025-09-170
OAAI
Mononuclear phagocytes in blood and cerebrospinal fluid of patients with relapsing-remitting multiple sclerosis: Untreated and treated with anti-CD20 therapy

复发缓解型多发性硬化症患者血液和脑脊液中的单核吞噬细胞:未经治疗和接受抗CD20治疗的患者

2025-09-080
PRE
Clinical and mechanistic effects of cladribine in relapsing multiple sclerosis: 2-year results from the MAGNIFY-MS Study

克拉屈滨在复发型多发性硬化中的临床和机制性作用:MAGNIFY-MS研究2年结果

2025-07-310
OA
Summary of Research: Blood Biomarker Dynamics in People with Relapsing Multiple Sclerosis Treated with Cladribine Tablets: Results of the 2-Year MAGNIFY-MS Study

研究总结:接受克拉屈滨片治疗复发型多发性硬化患者的血液生物标志物动态变化:MAGNIFY-MS研究2年结果

2025-07-040
OAAI
Blood biomarker dynamics in people with relapsing multiple sclerosis treated with cladribine tablets: results of the 2-year MAGNIFY-MS study

克拉屈滨片治疗复发性多发性硬化症患者的血液生物标志物动态: 2年MAGNIFY-MS研究结果

2025-02-030
OAAI
Temporal Dynamics of Plasma Neurofilament Light in Blood Donors With Preclinical Multiple Sclerosis

临床前多发性硬化症献血者血浆神经丝光的时间动力学

2025-01-010
PRE
Risk of hypertension in patients with multiple sclerosis treated with teriflunomide compared to dimethyl fumarate: A nationwide cohort study in Denmark

与富马酸二甲酯相比,特利氟米特治疗多发性硬化患者的高血压风险: 丹麦的一项全国性队列研究

2024-12-040
PRE
Patterns and predictors of multiple sclerosis phenotype transition

多发性硬化表型转变的模式和预测因素

2024-11-230
OAAI